Suppr超能文献

相似文献

1
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference.
Thorax. 2010 Feb;65(2):173-7. doi: 10.1136/thx.2009.113498. Epub 2009 Dec 8.
2
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2008 Jan 1;177(1):75-81. doi: 10.1164/rccm.200705-732OC. Epub 2007 Sep 27.
4
Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study.
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241275329. doi: 10.1177/17534666241275329.
6
Oxygen saturation recovery after 6-minute walk test in patients with idiopathic pulmonary fibrosis.
BMC Pulm Med. 2024 Jul 31;24(1):373. doi: 10.1186/s12890-024-03188-2.
7
Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
Am J Respir Crit Care Med. 2011 May 1;183(9):1231-7. doi: 10.1164/rccm.201007-1179OC. Epub 2010 Dec 3.
8
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
J Rheumatol. 2009 Feb;36(2):330-6. doi: 10.3899/jrheum.080447. Epub 2009 Jan 22.
10
Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial.
Sci Rep. 2025 Jan 23;15(1):3007. doi: 10.1038/s41598-025-87474-x.

引用本文的文献

2
Are the gains from pulmonary rehabilitation the same in idiopathic pulmonary fibrosis and other interstitial lung diseases?
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Sep 24;41(3):e2024038. doi: 10.36141/svdld.v41i3.15530.
5
Physical activity in idiopathic pulmonary fibrosis: Longitudinal change and minimal clinically important difference.
Chron Respir Dis. 2023 Jan-Dec;20:14799731231221818. doi: 10.1177/14799731231221818.
6
Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases.
ERJ Open Res. 2023 Aug 21;9(4). doi: 10.1183/23120541.00027-2023. eCollection 2023 Jul.
9
Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosis.
ERJ Open Res. 2023 Mar 27;9(2). doi: 10.1183/23120541.00637-2022. eCollection 2023 Mar.

本文引用的文献

1
Small changes in six-minute walk distance are important in diffuse parenchymal lung disease.
Respir Med. 2009 Oct;103(10):1430-5. doi: 10.1016/j.rmed.2009.04.024. Epub 2009 May 23.
2
Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.
Am J Respir Crit Care Med. 2008 Nov 1;178(9):948-55. doi: 10.1164/rccm.200709-1446OC. Epub 2008 Jul 31.
4
Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.
Respirology. 2008 May;13(3):394-9. doi: 10.1111/j.1440-1843.2007.01205.x.
5
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2008 Jan 1;177(1):75-81. doi: 10.1164/rccm.200705-732OC. Epub 2007 Sep 27.
6
Health-related quality of life in patients with idiopathic pulmonary fibrosis--cross-sectional and longitudinal study.
Intern Med. 2007;46(18):1533-42. doi: 10.2169/internalmedicine.46.6218. Epub 2007 Sep 14.
9
Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD.
Respir Med. 2007 Apr;101(4):833-8. doi: 10.1016/j.rmed.2006.06.030. Epub 2006 Sep 8.
10
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.
Am J Respir Crit Care Med. 2006 Oct 1;174(7):803-9. doi: 10.1164/rccm.200604-488OC. Epub 2006 Jul 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验